Overview

Topical Bimatoprost in the Treatment of Migraine

Status:
Unknown status

Trial end date:
2019-06-30

Target enrollment:

Participant gender:

Summary

The study is to assess the effectiveness of topically applied bimatoprost in reducing migraine headache frequency, severity, and duration. It will also assess the effect of topical bimatoprost on quality of life.

Phase:

Phase 2

Details

Lead Sponsor:

Manistee Partners

Treatments:

Bimatoprost
Pharmaceutical Solutions